logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

再生元 Moderna 冠状病毒 药物 疫苗

Healthcare Roundup – Regeneron expects coronavirus med to be ready by August, Moderna advances coronavirus vaccine candidate into the clinic

Mar 4, 2020

Life Science

罗氏 Actemra 冠状病毒

China approves use of Roche arthritis drug for coronavirus patients

Mar 4, 2020

Life Science

英特尔 联想 华大基因

Intel, Lenovo Help BGI Genomics Speed Up Coronavirus Genome Analysis

Mar 4, 2020

Life Science

美联储 国家灾难计划 冠状病毒 礼来

Healthcare Roundup – Feds mull use of national disaster program for coronavirus care, Coronavirus outbreak to not affect supply of medicines

Mar 3, 2020

Life Science

美国Abpro在亚洲上市免疫肿瘤学和眼科药物

Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets

Mar 3, 2020

Life Science

Naturally Splendid Ships Container of Hemp to Southeast Asia

Mar 3, 2020

Life Science

Schrödinger 谷歌 美国 冠状病毒计划

Healthcare Roundup – Schrödinger teams up with Google, U.S. authorities ramp up coronavirus plans

Mar 3, 2020

Life Science

吉利德 Forty Seven

Gilead to Acquire Immuno-Oncology Company Forty Seven for $4.9 Billion

Mar 2, 2020

Life Science

Generex 北京中华 冠状病毒 疫苗

Generex Signs Contract with Chinese Partners Beijing Zhonghua Investment Fund Management Co., LTD and Sinotek-Advocates International Industry Development (Shenzhen) Co., Ltd. to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccine Technology

Mar 2, 2020

Life Science

四环医药 冠状病毒

Sihuan Pharma Starts China Trials of Favipiravir to Treat COVID-19

Mar 2, 2020

Life Science

医疗保健精选——冠状病毒推高股价,赛诺菲为慈善调查案支付1,185万美元和解费

Healthcare Roundup – Another big session in store for coronavirus names,Sanofi to pay $11.85M to resolve drug charity probe

Feb 28, 2020

Life Science

和铂医药 CLTA-4抗体

Harbour BioMed to Begin US Trials of CLTA-4 Antibody

Feb 28, 2020

Life Science

Berkeley Lights 新冠肺炎

Researchers Worldwide Are Using Berkeley Lights’ Beacon Platform To Combat COVID-19

Feb 28, 2020

Life Science

准确率超高! 平安新冠肺炎智能阅片系统助疫区医生更高效

Ping An Launches COVID-19 Smart Image-Reading System to Help Control the Epidemic

Feb 28, 2020

Life Science

AIM ImmunoTech Forty Seven 吉利德科学 冠状病毒

Healthcare Roundup – AIM ImmunoTech gets China entry boost for coronavirus drug, Gilead Sciences approaches Forty Seven

Feb 27, 2020

Life Science

Ovation Science (CSE OVAT)

Ovation Ships First Order of DermSafe by Air to China to Help Combat the Coronavirus (COVID-19)  

Feb 27, 2020

Life Science

Naturally Splendid Announces Purchase Order and Provides Update on CHFA Expo West

Feb 27, 2020

Life Science

萨医疗保健精选——吉利德启动新冠肺炎的三期研究,3M因口罩需求致股价上涨

Healthcare Roundup – Gilead initiates two Phase 3 studies for coronavirus, 3M climbs on mask demand

Feb 26, 2020

Life Science

  • ‹‹ Previous
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada